Orthofix Medical Inc. Increase (Decrease) in Accrued Liabilities
Orthofix Medical Inc. (OFIX) reported Increase (Decrease) in Accrued Liabilities of -$83.18 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-04-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2015-04-29
- Orthofix Medical Inc. increase (decrease) in accrued liabilities for the quarter ending 2012-12-31 was -$84.24M, a 295.44% decline year-over-year.
- Orthofix Medical Inc. increase (decrease) in accrued liabilities for the quarter ending 2012-09-30 was $373.00K.
- Orthofix Medical Inc. increase (decrease) in accrued liabilities for the quarter ending 2011-12-31 was $43.10M.
- Orthofix Medical Inc. increase (decrease) in accrued liabilities for the quarter ending 2011-09-30 was $0.00.
- Orthofix Medical Inc. increase (decrease) in accrued liabilities for fiscal 2012 was -$83.18M, a 193.35% decline from fiscal 2011.
- Orthofix Medical Inc. increase (decrease) in accrued liabilities for fiscal 2011 was $89.10M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2012-12-31 | -$84.24M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-29 | -$83.86M derived: sum of 2 quarters · filed 2015-04-29 | -$83.18M 10-K · filed 2015-04-29 | -$82.50M 10-K · filed 2013-03-01 | |||
| 2012-09-30 | $373.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-25 | $1.06M 10-Q · filed 2014-03-25 | $1.69M 10-Q · filed 2012-11-02 | ||||
| 2012-06-30 | $686.00K 10-Q · filed 2014-03-24 | $1.36M 10-Q · filed 2012-07-30 | |||||
| 2011-12-31 | $43.10M derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-03-31 | $43.10M derived: sum of 2 quarters · filed 2015-03-31 | $43.10M derived: sum of 3 quarters · filed 2015-03-31 | $89.10M 10-K/A · filed 2015-03-31 | $88.46M 10-K · filed 2012-02-29 | ||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $0.00 derived: sum of 2 quarters · filed 2012-11-02 | $46.00M 10-Q · filed 2012-11-02 | ||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | $46.00M 10-Q · filed 2012-07-30 | |||||
| 2011-03-31 | $46.00M 10-Q · filed 2012-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |